New UCLA research using mouse models and human genetic data has uncovered a critical factor in kidney scarring, offering a promising precision...
Vous n'êtes pas connecté
Ryuji Morizane, MD, PhD, of the Department of Medicine at Massachusetts General Hospital, is the senior/corresponding author of a new paper published in Signal Transduction and Targeted Therapy, "AAV for gene therapy drives a nephrotoxic response via NFκB in kidney organoids."
New UCLA research using mouse models and human genetic data has uncovered a critical factor in kidney scarring, offering a promising precision...
Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on...
THURSDAY, Sept. 25, 2025 -- Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder...
THURSDAY, Sept. 25, 2025 -- Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder...
THURSDAY, Sept. 25, 2025 -- Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney...
THURSDAY, Sept. 25, 2025 -- Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney...
An experimental gene therapy from uniQure slowed the progression of Huntington’s disease by 75 percent over...
An experimental gene therapy from uniQure slowed the progression of Huntington’s disease by 75 percent over...
An NIHR─supported study into a new gene therapy treatment for Huntington's disease has revealed positive results.
Achieved expedited enrollment completion of first two Cohorts in Phase 1/2 Audiogene clinical trial evaluating SENS-501, the Company’s gene therapy...